SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation.
10 references·1 citing·38 second hop
The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation. (1999)The effect of a copay increase on pharmac…The Demand for Health: A Theoretical and Empirical Investigation (2017)The Demand for Health: A Theo…The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members. (1997)The impact of increasing pati…The Effect of Increased Prescription Drug Cost-Sharing on Medical Care Utilization and Expenses of Elderly Health Maintenance Organization Members (1997)The Effect of Increased Presc…The effects of copayments and generic substitution on the use and costs of prescription drugs. (1993)The effects of copayments and…A Critical Analysis of Studies of State Drug Reimbursement Policies: Research in Need of Discipline (1993)A Critical Analysis of Studie…The Effect of Drug Co-Payments on Utilization and Cost of Pharmaceuticals in a Health Maintenance Organization (1990)The Effect of Drug Co-Payment…Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)Health insurance and the dema…Use of medical care in the Rand Health Insurance Experiment. Diagnosis- and service-specific analyses in a randomized controlled trial. (1986)Use of medical care in the Ra…The differential impact of copayment on drug use in a Medicaid population. (1985)The differential impact of co…The demand for prescription drugs as a function of cost-sharing (1985)The demand for prescription d…Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs (2003)Retrospective, long-term foll…The Demand for Health: A Theoretical and Empirical Investigation (1975)A Comparison of Alternative Models for the Demand for Medical Care (1983)Does Free Care Improve Adults' Health? (1983)Cross-national price differences for pharmaceuticals: how large, and why? (2000)Employer Drug Benefit Plans and Spending on Prescription Drugs (2002)The effects of prescription drug cost sharing: a review of the evidence. (2005)Payment Restrictions for Prescription Drugs under Medicaid (1987)Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization (2001)Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors (2002)Pharmaceutical policies: effects of cap and co-payment on rational drug use (2008)Health Care Financing Review (1980)Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes (1991)The effects of cost-sharing on essential drug prescriptions, utilization of medical care and outcomes after acute myocardial infarction in elderly patients. (2002)Effect of a medication copayment increase in veterans with schizophrenia. (2007)Cost-sharing: effects on spending and outcomes. (2010)Equilibrium in Competitive Insurance Markets: An Essay on the Economics of Imperfect Information (1976)Limited-dependent and qualitative variables in econometrics (1983)Medical Care Costs: How Much Welfare Loss? (1992)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)The Oregon Health Insurance Experiment: Evidence from the First Year* (2012)Best care at lower cost: the path to continuously learning health care in America (2014)Adjusting Medicare capitation payments using prior hospitalization data. (1989)The Case for a Medicare Drug Coverage Benefit: A Critical Review of the Empirical Evidence (2001)Effect of Increased Cost-Sharing on Oral Hypoglycemic Use in Five Managed Care Organizations (2005)Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures (2008)The theory and practice of econometrics (1986)Some Interim Results from a Controlled Trial of Cost Sharing in Health Insurance (1981)Recent Developments and Future Issues in the Use of Health Status Assessment Measures in Clinical Settings (1992)High and Rising Health Care Costs. Part 1: Seeking an Explanation (2005)Behavioral Hazard in Health Insurance * (2015)A comparison of alternative models of prescription drug utilization (1995)Pharmaceutical policies: effects of cap and co-payment on rational use of medicines (2015)The family as producer of health — an extended grossman model (2000)IMMIGRANT SELECTION SYSTEMS AND IMMIGRANT HEALTH (2008)Parental Education and Child Health: Evidence from a Natural Experiment in Taiwan (2009)Inadequate Prescription-Drug Coverage for Medicare Enrollees — A Call to Action (1999)Transforming Insurance Coverage Into Quality Health Care (2000)Effective healthcare cost-containment policies: A systematic review (2018)
this work references cited by second hop

References

  • 1987Health insurance and the demand for medical care: evidence from a randomized experiment.2,043 cited
  • 2017The Demand for Health: A Theoretical and Empirical Investigation408 cited
  • 1986Use of medical care in the Rand Health Insurance Experiment. Diagnosis- and service-specific analyses in a randomized controlled trial.341 cited
  • 1985The demand for prescription drugs as a function of cost-sharing286 cited
  • 1990The Effect of Drug Co-Payments on Utilization and Cost of Pharmaceuticals in a Health Maintenance Organization188 cited
  • 1993A Critical Analysis of Studies of State Drug Reimbursement Policies: Research in Need of Discipline169 cited
  • 1997The Effect of Increased Prescription Drug Cost-Sharing on Medical Care Utilization and Expenses of Elderly Health Maintenance Organization Members112 cited
  • 1985The differential impact of copayment on drug use in a Medicaid population.112 cited
  • 1997The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members.99 cited
  • 1993The effects of copayments and generic substitution on the use and costs of prescription drugs.73 cited

Cited by

  • 2003Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs68 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work